EODData

SHE, 301277: Henan Newland Pharmaceutical Co. Ltd. A

24 Sep 2026
LAST:

10.24

CHANGE:
 0.21
OPEN:
10.38
HIGH:
10.51
ASK:
0.00
VOLUME:
2.49M
CHG(%):
2.01
PREV:
10.45
LOW:
10.22
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Sep 2610.3810.5110.2210.242.49M
23 Sep 2610.3810.5510.3410.453.42M
22 Sep 2610.3010.5310.2610.425.15M
21 Sep 269.9310.589.8610.426.39M
18 Sep 269.7810.089.789.862.4M
17 Sep 269.629.839.609.791.79M
16 Sep 269.629.749.549.691.27M
15 Sep 269.919.919.639.651.82M
14 Sep 269.879.929.649.871.84M
11 Sep 269.879.879.639.702.26M

PROFILE

Name:Henan Newland Pharmaceutical Co. Ltd. A
About:Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers pharmaceutical intermediates, including L-4-hydroxyphenylglycine methyl ester, L-hydroxyphenylglycine potassium salt, L-4-hydroxyphenylglycine, and p-Toluenesulfonic acid. It also provides APIs, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, gatifloxacin, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge City, China.
Sector:Healthcare
Address:East side of the southern section of Weiwu Road, Changge City, China, 461500
Website:https://www.newlandpharma.com
ISIN:CNE1000065K2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:40.73 
Price to Sales:6.30 
Price to Book:2.62 
Profit Margin:0.15 
Operating Margin:0.20 
Return on Assets:0.03 
Return on Equity:0.06 
DivYield:0.02 
Div/Share:0.29 
Revenue:659.54M 
EBITDA:173.32M 
Shares:392.08M 
Market Cap:4.015B 

TECHNICAL INDICATORS

MA5:10.280.4%
MA10:10.012.3%
MA20:10.091.5%
MA50:10.270.3%
MA100:10.121.2%
MA200:11.158.9%
STO9:63.44
STO14:63.44
RSI14:53.39
WPR14:-26.25
MTM14:0.07
ROC14:0.01 
ATR:0.28 
Week High:10.583.3%
Week Low:9.606.7%
Month High:10.896.3%
Month Low:9.548.9%
Year High:13.8435.2%
Year Low:8.4521.2%
Volatility:26.67 

RECENT SPLITS

Date Ratio
16 Apr 20251.4-1
10 May 20241.4-1
10 May 20231-1

RECENT DIVIDENDS

Date Amount
16 Apr 2025$0.20
10 May 2024$0.10
10 May 2023$0.13
10 Nov 2022$0.04
11 Aug 2022$0.04
12 May 2022$0.04
17 Feb 2022$0.04
11 Nov 2021$0.04
12 Aug 2021$0.04
06 May 2021$0.04